Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Crinetics Pharmaceuticals Inc.

Clinical trials sponsored by Crinetics Pharmaceuticals Inc., explained in plain language.

Crinetics Pharmaceuticals Inc. CRNX NASDAQ

A biopharmaceutical company developing therapies for endocrine diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet finished but already full! 1 Completed 3 Terminated 3

New drug interaction study aims to make atumelnant safer

Knowledge-focused Ongoing

This study is testing how a new drug called atumelnant interacts with other medications in 46 healthy adults. Participants will receive atumelnant along with drugs like carbamazepine, midazolam, digoxin, and metformin to see how the body processes them. The goal is to gather safe…

Phase: PHASE1 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Knowledge-focused

Last updated Jul 08, 2026 00:00 UTC